In vivo activity and pharmacokinetic evaluation of a novel long-acting carbapenem antibiotic, MK-826 (L-749,345).
about
Pharmacodynamic profile of ertapenem against Klebsiella pneumoniae and Escherichia coli in a murine thigh modelIn vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates.Comparative In vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infections.In vitro antianaerobic activity of ertapenem (MK-0826) compared to seven other compounds.Pharmacodynamic assessment of ertapenem (MK-0826) against Streptococcus pneumoniae in a murine neutropenic thigh infection model.Pharmacokinetics of ertapenem in healthy young volunteers.Bacteremia due to Bacteroides fragilis group: distribution of species, beta-lactamase production, and antimicrobial susceptibility patternsDaily variations in ceftriaxone pharmacokinetics in ratsTissue penetration by ertapenem, a parenteral carbapenem administered once daily, in suction-induced skin blister fluid in healthy young volunteers.Pharmacokinetics of intramuscularly administered ertapenemIn vitro activities of MK-826 (L-749,345) against 363 strains of anaerobic bacteria.In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia.In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers.Antipneumococcal activity of ertapenem (MK-0826) compared to those of other agents.Comparative in vitro activities of ertapenem (MK-0826) against 469 less frequently identified anaerobes isolated from human infections.
P2860
Q33555094-B6E4D154-4AD4-4D3B-BC23-E25EC6E5676EQ33976270-879A82EA-0F08-4ACB-993C-51175C679877Q33980464-57A801AA-ED1A-431C-99C7-123C32D6A29BQ34104471-E1179505-8D91-44BA-9DF6-BA01CB57FEBFQ34112691-9BB8AABC-B901-450F-9B94-23062A3A47E6Q34141850-F3E3692E-FEE5-4BD5-B839-51DE8512E3CDQ34721737-42F57116-0D2E-42A6-90D5-1BC7817DC312Q34824282-D129E83B-5026-4F28-B1EF-056E75E3EC7EQ34883132-D041E9F3-A9B1-4B3B-834D-5B8BB5645B31Q34938460-9C1C5C80-1850-4848-90F2-7EFF3AB10014Q39474748-D95232BD-1117-489C-B668-CD0C10FD4975Q39477537-19BC8BC7-7C3B-465D-BD61-71A2E36E1359Q39477617-2F04CE76-15E0-45D3-A521-A7172895C20CQ39650917-0CB644F6-4455-4EE2-97DD-02AABEE2D1B2Q39651410-A889A958-48C3-42FD-9A27-9A03D7EDD11D
P2860
In vivo activity and pharmacokinetic evaluation of a novel long-acting carbapenem antibiotic, MK-826 (L-749,345).
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
In vivo activity and pharmacok ...... ntibiotic, MK-826 (L-749,345).
@ast
In vivo activity and pharmacok ...... ntibiotic, MK-826 (L-749,345).
@en
type
label
In vivo activity and pharmacok ...... ntibiotic, MK-826 (L-749,345).
@ast
In vivo activity and pharmacok ...... ntibiotic, MK-826 (L-749,345).
@en
prefLabel
In vivo activity and pharmacok ...... ntibiotic, MK-826 (L-749,345).
@ast
In vivo activity and pharmacok ...... ntibiotic, MK-826 (L-749,345).
@en
P2093
P2860
P1476
In vivo activity and pharmacok ...... ntibiotic, MK-826 (L-749,345).
@en
P2093
J G Sundelof
J J Jackson
L S Gerckens
R K Thompson
P2860
P304
P407
P577
1998-08-01T00:00:00Z